Skip to content

Study to Evaluate the Effectiveness of the Device in Detection of Abnormal Findings on Chest X-ray

Single-Center, Retrospective, Pivotal Study to Evaluate the Effectiveness of Investigational Device (Lunit INSIGHT CXR) in Detection of Abnormal Findings on Chest Radiographs

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05614232
Enrollment
700
Registered
2022-11-14
Start date
2020-02-11
Completion date
2020-07-01
Last updated
2022-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Disease

Brief summary

This study aims to evaluate the effectiveness of the investigational device (Lunit INSIGHT CXR) in the detection of chest abnormalities

Detailed description

In the study, the standalone performance of Lunit INSIGHT CXR was primarily assessed by comparing the analysis results from the investigational device and reference standards in the detection of 10 abnormal radiologic findings - atelectasis, calcification, cardiomegaly, consolidation, fibrosis, mediastinal widening, nodule/mass, pleural effusion, pneumoperitoneum, and pneumothorax.

Interventions

RADIATIONChest X-ray

Chest radiographs

Sponsors

Lunit Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
14 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Chest radiographs of aged 14 years or older * Conventional PA or AP chest radiographs * Chest radiographs with confirmed radiology reports

Exclusion criteria

* Chest radiographs taken in postures other than PA and AP * Chest radiographs from dual-energy radiography * Invert-grayscale chest radiographs

Design outcomes

Primary

MeasureTime frameDescription
the effectiveness of the investigational devicethrough study completion, an average of 6 monthsArea Under the Receiver Operating Characteristic Curve (ROC AUC) of the investigational device in detection of overall target radiologic findings (detection of any abnormal findings among ten target radiologic findings)

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026